OQS
RUBY

Occudo Quantitative Strategies’s Rubius Therapeutics, Inc RUBY Stock Holding History

Occudo Quantitative Strategies’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,975
Closed -$9K – 1503
2022
Q3 		$9K Sell
19,975
-924
-4% -$693 ﹤0.01% 1134
2022
Q2 		$18K Buy
20,899
+10,125
+94% +$17K ﹤0.01% 1098
2022
Q1 		$59K Buy
+10,774
New +$68.4K ﹤0.01% 1066
2021
Q3 		– Sell
-10,542
Closed -$257K – 1197
2021
Q2 		$257K Buy
+10,542
New +$264K 0.04% 661

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's RUBY Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Rubius Therapeutics, Inc (RUBY) in Q4 2022, closing a stake of 19,975 shares — an estimated $9K sold.

Occudo Quantitative Strategies first reported a position in RUBY in Q2 2021 and held it in 4 quarters. The position peaked at $257K in Q2 2021. 42 funds tracked by Wall St. Rank hold RUBY as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Rubius Therapeutics, Inc position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 19,975 Rubius Therapeutics, Inc shares in Q4 2022, an estimated $9K.
  • Occudo Quantitative Strategies first reported a position in Rubius Therapeutics, Inc in Q2 2021 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Rubius Therapeutics, Inc position peaked at $257K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.